TABLE 11.

Steroid hormone levels at baseline and in response to the HERITAGE exercise program in women by menopause and hormonal drug status.

Variables	Premenopausal, No OC (n = 167)		Premenopausal, OC (n = 88)		Postmenopausal, No HRT (n = 24)		Postmenopausal, HRT (n = 22)
	Before	After	Before	After	Before	After	Before	After
ADTG	101 ± 55	98 ± 55	82 ± 41	84 ± 43	66 ± 37	68 ± 41	61 ± 45	58 ± 42
ALDO	0.2 ± 0.2	0.2 ± 0.2	0.3 ± 0.2	0.3 ± 0.2	0.2 ± 0.1	0.2 ± 0.1	0.2 ± 0.2	0.2 ± 0.2
CORT	358 ± 134	414 ± 174	662 ± 275	683 ± 305	368 ± 129	401 ± 137	369 ± 129	427 ± 165
DELTA4	2.6 ± 1.5	2.6 ± 1.5	2.5 ± 1.6	2.8 ± 1.3	1.5 ± 0.8	1.5 ± 0.8	1.3 ± 0.6	1.3 ± 0.7
DHEA	14.8 ± 9.6	14.5 ± 10.2	16.3 ± 11.0	17.0 ± 9.7	7.9 ± 4.8	8.5 ± 7.0	6.8 ± 4.0	7.2 ± 5.5
DHEAE	8.4 ± 5.4	7.5 ± 4.8*	7.9 ± 5.5	8.2 ± 5.4	5.6 ± 3.7	5.6 ± 3.5	3.8 ± 2.0	4.5 ± 2.5
DHEAS	4023 ± 2212	3823 ± 2185*	4132 ± 2271	4087 ± 2186	1882 ± 1019	1930 ± 1061	1677 ± 830	1709 ± 1002
DHT	0.5 ± 0.2	0.6 ± 0.4	0.5 ± 0.3	0.5 ± 0.3	0.5 ± 0.3	0.5 ± 0.2	0.4 ± 0.1	0.4 ± 0.2
DIOLG	15.6 ± 8.1	16.1 ± 9.1	12.5 ± 5.8	13.4 ± 7.2*	12.1 ± 6.5	11.8 ± 5.5	9.4 ± 5.8	9.2 ± 5.8
E2	130 ± 106	137.1 ± 126	125 ± 221	105 ± 127	45 ± 55	36 ± 51	333 ± 389	325 ± 415
OHPRG	2.3 ± 1.7	2.7 ± 3.4	2.1 ± 1.4	2.1 ± 1.3	1.7 ± 0.9	1.6 ± 0.9	1.2 ± 0.8	1.2 ± 0.8
PREGE	15.2 ± 9.0	14.5 ± 8.7	13.4 ± 9.4	14.3 ± 10.7	11.2 ± 6.3	10.9 ± 7.3	6.7 ± 3.0	7.3 ± 4.1
PROG	1.6 ± 0.8	1.5 ± 0.8	1.4 ± 0.7	1.4 ± 0.7	0.9 ± 0.6	0.8 ± 0.5	0.7 ± 0.5	0.7 ± 0.4
SHBG	66.1 ± 27.0	68.4 ± 34.3	113.3 ± 58.2	109 ± 55.2	65.9 ± 24.4	62.7 ± 25.6	118.6 ± 61.8	113.2 ± 59.0
TESTO	1.3 ± 0.5	1.3 ± 0.5	1.4 ± 0.6	1.4 ± 0.6	1.4 ± 1.2	1.1 ± 0.4	1.1 ± 0.5	1.0 ± 0.5

Units for all variables are nmol·L⁻¹, except E2 (pmol·L⁻¹).

*P < 0.05 for difference between baseline and posttraining mean values.

OC, oral contraceptives.

Adapted from He et al. (28) and unpublished data.